TD Cowen Initiates Coverage On Teva Pharmaceutical Indus with Buy Rating, Announces Price Target of $55

TD Cowen has initiated coverage on Teva Pharmaceutical Industries (NYSE: TEVA) with a Buy rating. The firm has set a price target of $55 for the company's stock.